Jonathan Hovda, MD
Pulmonary Disease · Minneapolis, MNNPI 1689836942
Payments from drug & device makers
Across 301 payments — averaging $2369.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galvanize Therapeutics, Inc$422K
- Johnson & Johnson$187K
- Ethicon Endo-surgery Inc.$51K
- Intuitive Surgical$19K
- Elucent Medical$15K
- Medtronic$9K
- plus $11K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galvanize Therapeutics, Inc | 20 | $421,642 |
| Johnson & Johnson(2 entities) | 109 | $187,234 |
| Ethicon Endo-surgery Inc. | 27 | $51,489 |
| Intuitive Surgical | 76 | $18,888 |
| Elucent Medical | 9 | $14,545 |
| Medtronic | 22 | $8,544 |
| Medical Device Business Services, Inc. | 3 | $6,072 |
| Siemens Medical Solutions USA, Inc. | 3 | $1,512 |
| Pulmonx Corporation | 8 | $1,489 |
| Covidien LP | 2 | $1,112 |
| Auris Health, Inc. | 3 | $188 |
| Optellum Ltd | 1 | $150 |
| Olympus America Inc. | 3 | $125 |
| Janssen Research & Development, LLC | 2 | $60 |
| Imbio Inc. | 1 | $57 |
| Philips North America LLC | 3 | $45 |
| Pinnacle Biologics, Inc | 2 | $44 |
| Boehringer Ingelheim | 2 | $32 |
| GSK | 1 | $22 |
| Insmed, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Mylan Specialty L.p. | 1 | $14 |
| Veran Medical Technologies, Inc. | 1 | $6 |
How this compares
$713,302 in reported general payments places this provider in the 95th percentile of 261 pulmonary disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Minneapolis
- Hyun KimMinneapolis$1.5M
- Joanne BillingsMinneapolis$1.5M
- Patrick WrightMinneapolis$817K
- Kevin GrullonMinneapolis$618K
- Ralph SteeleMinneapolis$298K
- Marshall HertzMinneapolis$289K
- David IngbarMinneapolis$272K
- Mitchell KayeMinneapolis$248K
- Jordan DunitzMinneapolis$147K
- Ronald ReilkoffMinneapolis$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.